MMJ Recs

FEBRUARY 10, 2024

The journey begins with early debates around the medicinal use of cannabis, leading to the eventual establishment of the state’s medical marijuana program. Scientific research, patient testimonials, and a broader understanding of the plant’s medicinal properties have fundamentally altered public views.

Research and Development 105

Research and Development Marijuana History Legislation 105

SpeedWeed

JULY 6, 2021

Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . This new program is being funded by private investors, including Matt Wullenweg, developer of WordPress, and philanthropist Tim Ferriss.

Policy 52

Policy Law Research and Development Therapy 52

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges remain in ensuring equitable access to participation in the legal cannabis market and addressing disparities in ownership and representation.

Legalization 52

Legalization Access Programs Education 52

Cannabis Law Report

JULY 1, 2022

We are currently recruiting for a Program Analyst to develop, coordinate, and analyze our tracking systems. The position will be developing and evaluating OPS’s Training program, Licensing and Compliance (TLC) system as well as OPS’s product tracking system. Research and recommend systems, policies, and operations.

Programs 52

Programs Compliance Compliance Research and Development 52

MMJ Recs

MARCH 16, 2024

Economic Growth and Job Creation of the medical marijuana industry The medical cannabis sector serves as a catalyst for economic expansion and workforce development in regions where it’s legalized. Policy decisions related to taxation, zoning, and advertising also impact the industry’s operations and growth trajectory.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

MARCH 8, 2022

WORCESTER, MA— The Cannabis Control Commission (Commission) hosted a virtual orientation seminar on Thursday, March 3 for participants of the third cohort of Massachusetts’ first-in-the-nation Social Equity Program. Chairman Steven Hoffman and Social Equity Program Participant Aaron Goines then hosted a business planning seminar.

Programs 52

Programs Research and Development Access Business 52

MMJ Recs

OCTOBER 26, 2023

Understanding MMJ regulations on a state-by-state basis is essential for both patients seeking access to MMJ and the businesses and professionals operating within this industry. Some states have broadly permissive MMJ laws, while others have more restrictive programs. Indiana: Indiana has strict marijuana laws and no MMJ program.

Law 98

Law Marijuana Programs Dispensary 98

Americans for Safe Access

OCTOBER 26, 2021

Check out the October 2021 issue of the ASA Activist Newsletter for updates on developments that matter for medical cannabis advocates, including Congressional action on the revived MORE Act that could end federal prohibition. In the activist profile, you'll learn about Michelle J.

Research and Development 130

Research and Development Education Events Policy 130

MMJ Recs

MARCH 20, 2024

Many dispensaries also offer additional services such as educational resources, patient consultations, and ongoing support programs to address patient concerns and enhance their overall treatment experience. These expansions aim to increase patient access and address supply shortages experienced in the past.

Dispensary 52

Dispensary Programs Access Patients 52

Cannabis Law Report

JULY 13, 2022

WORCESTER, Mass. , July 13, 2022 /PRNewswire/ — Green Flower, a California -based education company focused on the cannabis industry, announced four new online certificate programs in partnership with Worcester Polytechnic Institute (WPI). The programs are now open for enrollment with classes starting on September 5.

Education 52

Education Programs Research and Development Agriculture 52

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Americans for Safe Access

MAY 21, 2019

Americans for Safe Access Wants to Help You Navigate the Federal Regulatory Process. In fact, the FDA itself specifies that the FDA comment process is not a popularity contest in which the agency will adopt the policy position promoted by the greatest number of commenters.

Research and Development 144

Research and Development Policy Food Programs 144

NORML

FEBRUARY 15, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. Send a message to your lawmakers in support of medical marijuana access. AL resident? KY resident? MD resident?

Legislation 272

Legislation Decriminalization Access Patients 272

United Patients Group

JANUARY 4, 2024

These roles complement healthcare practitioners’ vital work and shape the future of healthcare delivery, policy, and administration. Tasked with overseeing budgets, managing personnel, and implementing policies, healthcare administrators are instrumental in maintaining the integrity of healthcare delivery systems.

Research and Development 52

Research and Development Patients Data Policy 52

PrestoDoctor

JANUARY 30, 2024

Connection between cannabis use and psychosis The connection between cannabis use and psychosis has been a topic of much research and debate. Studies have shown that individuals who use cannabis are at an increased risk of developing psychotic symptoms. These interactions may contribute to the development of cannabis-induced psychosis.

Research and Development 52

Research and Development Treatment Conditions Education 52

Project CBD

JULY 28, 2023

From 1994 to 2013, he was employed as a principal investigator at DuPont Central Research and Development. Producing and selling psychoactive products outside the regulatory auspices of the FDA or a state-regulated cannabis program is not ethical. with unknown pharmacological and safety profiles.”

THC 212

THC Cannabinoids Hemp Research and Development 212

Cannabis Law Report

SEPTEMBER 10, 2021

The announcement of a partnership between Clerkenwell Health and Octarine Bio signals a momentous time for the growth and development of the European psychedelic ecosystem. Clerkenwell Health is a psychedelic specialist clinical research organisation, based in the UK, backed with investment from VC Fund Vine Ventures, and Angel investors.

Research and Development 104

Research and Development Clinical Trials Therapy Environment 104

United Patients Group

JUNE 26, 2023

They often possess a more profound understanding of healthcare policies, advanced practice procedures, and innovative research methodologies. BSN to DNP programs in Massachusetts can be particularly advantageous for nurses aiming to enact significant changes in the health sector.

Research and Development 52

Research and Development Education Patients Policy 52

Cannabis Law Report

SEPTEMBER 9, 2021

The current public policies in local and state cannabis ordinance and equity programs may enhance racial disparities if they follow the pattern of exclusion and criminalization that encompass past policies promoted as beneficial to African Americans but uphold racial capitalistic practices. Central Research Question.

Policy 105

Policy Research and Development Collective Banking 105

Cannabis Law Report

JANUARY 27, 2022

If passed the bill will establish the “Task Force on Psilocybin Equity” that will research problems relating to access and equity in Oregon’s emerging psilocybin program. Green Light Law Group assisted in drafting SB 1580 and is pleased to provide background on the bill’s development and future.

Research and Development 52

Research and Development Policy Access Legislation 52

MMJ Recs

DECEMBER 17, 2023

The Texas Compassionate Use Program (TCUP) represents the Lone Star State’s cautious foray into the realm of medical marijuana. Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals.

Law 52

Law Dispensary Clinical Trials Programs 52

Cannabis Law Report

JANUARY 12, 2022

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

NORML

JANUARY 4, 2019

Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. Legislation is pending, HB 350, to expand medical cannabis access. NH resident? GA resident?

Legislation 126

Legislation Clinical Trials Research and Development Access 126

Cannabis Law Report

JUNE 26, 2022

1 Despite what would appear to be increasingly lawful access to cannabis, it is still classified by U.S. IHEs are required to certify that they have an AOD prevention program in order to remain eligible for certain forms of federal funding and assistance. Certification Requirements.

Research and Development 52

Research and Development Education Programs Policy 52

SpeedWeed

FEBRUARY 19, 2021

Members share information, “develop more uniformity across state frameworks” and “assist federal, state and local jurisdictions that have approved or are weighing the legalization of cannabis.”. 18 missive to Congress, the CANNRA outlined its policy priorities, including: Reinstituting the Cole Memorandum.

Research and Development 52

Research and Development Marijuana Banking Policy 52

SMPL

AUGUST 14, 2019

The American Bar Association (ABA) adopted a resolution on Monday that calls on Congress to allow states to set their own marijuana policies and recommends rescheduling or descheduling cannabis under federal law.

Policy 40

Policy Research and Development Marijuana DEA 40

Cannabis Law Report

MAY 28, 2019

Veterans Struggle to Gain Access to Medical Marijuana. Thirty-three states and the District of Columbia have enacted medical marijuana programs. Despite this expansion military veterans often face greater obstacles to gaining access to medical marijuana than other groups. Current Issues in Marijuana Regulation. May 2, 2019.

Access 49

Access Marijuana Research and Development Programs 49

Cannabis Law Report

JANUARY 27, 2022

New York’s legislation includes a psilocybin services grant program that provides financial assistance to veterans and first responders who want to access psilocybin services. Like Oregon’s psilocybin program, Washington will issue licenses for (1) manufacturing, (2) service centers, (3) facilitators, and (4) testing.

Legalization 52

Legalization Research and Development Legislation Treatment 52

Cannabis Law Report

JUNE 29, 2021

DEI policies and integration across supply chain, vendor, recruitment, and employment practices. Development of strategic philanthropy plans, establishment of corporate nonprofit organizations and foundations, and establishment and certification of benefit corporations. Sustainability consulting and environmental compliance.

Hemp 90

Hemp Research and Development Supply Chain Policy 90

MMJ Recs

DECEMBER 22, 2023

Historically, marijuana was vilified and classified as a Schedule I controlled substance, which hindered both research and public acceptance. One of the key drivers of this shift is the increasing body of scientific research highlighting the medical properties of cannabinoids, the active compounds in marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

JULY 14, 2022

Register for our new digital learning program. Dear Sean, MAPS is excited to announce the launch of Psychedelic Fundamentals , an online psychedelic education program which provides people with accurate, evidence-based information about psychedelics. Psychedelic Fundamentals , An Online Education Curriculum. Register Now.

Education 52

Education Research and Development History Programs 52

Cannabis Law Report

FEBRUARY 10, 2022

Controlled research into psilocybin for therapeutic purposes reveals that it may allow people suffering from depression, anxiety, PTSD, and potentially addiction, to more easily face and overcome painful or stressful memories and experiences. Background. Psilocybin. Psilocybin is the hallucinogenic chemical found in “magic mushrooms.”

DEA 52

DEA Clinical Trials Policy Research and Development 52

Cannabis Law Report

AUGUST 15, 2022

The state has introduced a new program to compensate Maine cities and towns for costs they incur when opting to permit recreational, adult-use cannabis businesses. The Office of Cannabis Policy last week announced the launch of an online portal Maine municipalities can use to obtain reimbursement for up to $20,000 of those costs.

Recreational 52

Recreational Consumption Research and Development Safety 52

Cannabis Law Report

JULY 20, 2021

The creation of this standalone cannabis department is part of a larger effort to improve access to licensure, simplify regulatory oversight and support California businesses. Elliott was the Governor’s Senior Advisor on Cannabis at the Governor’s Office of Business and Economic Development. Biographies. Director – Nicole Elliott.

Research and Development 105

Research and Development Compliance Compliance Food 105

Veriheal

AUGUST 24, 2022

This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. Research and Testimonials Point to Psychedelics’ Therapeutic Benefits. The Natural Medicine Health Act: Pros and Cons.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

JULY 23, 2021

The bill includes several provisions for additional research to investigate the impact of legalization on public health, driving safety, and similar areas. Research, Training and Prevention. Cannabis research has been limited up to this point due to its status as a Schedule 1 controlled substance.

Research and Development 105

Research and Development DEA Programs State Laws 105

Cannabis Law Report

DECEMBER 1, 2021

As psychedelic medicine becomes more mainstream, we must ensure that all who participate in healing therapeutic sessions, both above ground and in ceremonial or underground therapeutic settings, are safe and accessible to all. She has developed and teaches InnerEthics™ in psychedelic psychotherapy trainings. Kylea Taylor, M.S.,

Safety 52

Safety Medicine Therapy Research and Development 52